Endogenous serum levels and surface receptor expression of GM-CSF and IL-3 in patients with myelodysplastic syndromes
- 31 December 1992
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 16 (12) , 1181-1186
- https://doi.org/10.1016/0145-2126(92)90116-o
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Detection of soluble IL‐2 receptor in the serum of patients with myelodysplastic syndromes: induction under therapy with GM‐CSFBritish Journal of Haematology, 1991
- Abnormal megakaryopoiesis in patients with myelodysplastic syndromes: analysis of cellular and humoral defectsBritish Journal of Haematology, 1989
- Delayed maturation of skin window macrophages in myelodysplastic syndromesLeukemia Research, 1989
- Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemiaBritish Journal of Haematology, 1988
- Lymphocyte interleukin 2 production and responsiveness are altered in patients with primary myelodysplastic syndromeBlood, 1987
- Human preleukaemia: do we have a model?British Journal of Cancer, 1987
- Immunoregulatory abnormalities in myelodysplastic disordersAmerican Journal of Hematology, 1986
- Myelodysplastic syndromes: a scoring system with prognostic significanceBritish Journal of Haematology, 1985
- Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders.Journal of Clinical Pathology, 1983
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982